News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Akhil Santhosh: TBCRC 048 – good activity for olaparib in BRCA1/2 advanced breast cancer
Breast Cancer/canceronco.com
Jan 22, 2025, 11:08

Akhil Santhosh: TBCRC 048 – good activity for olaparib in BRCA1/2 advanced breast cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:

“TBCRC 048: good activity for olaparib in somatic BRCA1/2 altered advanced breast cancer patients.

  • n=30
  • ORR 37%, CBR 53%, mPFS7.2months, DOR-12.4m.”

Akhil Santhosh: TBCRC 048 - good activity for olaparib in BRCA1/2 advanced breast cancer

Akhil Santhosh Breast Cancer
Special Coverage
Insight
Jan 22, 2025, 16:26
Tricking the Immune System: A New Approach to Targeting Cancer Cells by Mimicking Pig Organs
Career
Jan 22, 2025, 16:21
Michael A. Caligiuri - Candidate for Treasurer of AACR
Blog
Jan 22, 2025, 16:20
Milan Mishkovikj: United by Unique - Together, We Can Beat Cancer
Blog
Jan 22, 2025, 16:17
Why Should You Get the HPV Vaccine? - Onco Intelligence
Blog
Jan 22, 2025, 16:00
Accelerating Cancer Research and Innovation in Comprehensive Cancer Infrastructure - European Cancer Organisation
Science
Jan 22, 2025, 15:28
Clinical validation of the Intermediate-risk NMIBC Scoring System and Substratification Model
Blog
Jan 22, 2025, 15:27
The Future of Integrative Oncology: Bridging Cultures, Embracing Innovation and Fostering Unity - SIO
Science
Jan 22, 2025, 15:19
Francisco Conesa Buendía: Off-the-Shelf Cancer Immunotherapy - A Deep Dive into AlloCAR-NKT Cells
Blog
Jan 22, 2025, 15:18
Herbert Loong: Supporting Tim Yap from MD Anderson Cancer Center to represent AACR Board of Directors
Blog
Jan 22, 2025, 15:07
Trispecific antibodies for enhanced cancer immunotherapy
Science
Jan 22, 2025, 15:04
Elias Orouji: CAR-T Cell Therapy for Colorectal Cancer
Science
Jan 22, 2025, 14:59
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT)